{"instruction": "You are an expert in event extraction. Please extract events from the input that conform to the schema definition. Return an empty list for events that do not exist, and return NAN for arguments that do not exist. If an argument has multiple values, please return a list. Respond in the format of a JSON string.", "schema": [{"event_type": "potential therapeutic event", "trigger": true, "arguments": ["Treatment.Duration", "Subject.Disorder", "Subject.Gender", "Subject", "Combination.Drug", "Treatment", "Treatment.Freq", "Treatment.Dosage", "Treatment.Route", "Subject.Age", "Subject.Race", "Subject.Population", "Treatment.Disorder", "Effect", "Treatment.Time_elapsed", "Treatment.Drug"]}, {"event_type": "adverse event", "trigger": true, "arguments": ["Subject.Disorder", "Subject.Age", "Treatment.Time_elapsed", "Subject", "Effect", "Subject.Population", "Combination.Drug", "Treatment.Disorder", "Treatment.Dosage", "Treatment.Drug", "Subject.Race", "Treatment.Freq", "Treatment.Route", "Subject.Gender", "Treatment"]}], "input": "Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum-based chemotherapy, even in platinum-sensitive cases, because CBDCA hypersensitivity can occur even with low-dose CBDCA administration."}
{"potential therapeutic event": [], "adverse event": [{"trigger": "correlated ", "arguments": {"Subject.Disorder": "NAN", "Subject.Age": "NAN", "Treatment.Time_elapsed": "NAN", "Subject": "NAN", "Effect": "CBDCA hypersensitivity", "Subject.Population": "NAN", "Combination.Drug": "NAN", "Treatment.Disorder": "NAN", "Treatment.Dosage": "NAN", "Treatment.Drug": "platinum agents", "Subject.Race": "NAN", "Treatment.Freq": "NAN", "Treatment.Route": "NAN", "Subject.Gender": "NAN", "Treatment": "total dose of previously administered platinum agents"}}]}